
Monday, September 19, 2016 3:31:17 PM
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent PTN News
- Frontiers in Immunology Publishes Pre-Clinical Study of Palatin's Oral Formulation of PL8177 Demonstrating Therapeutic Effects in Inflammatory Bowel Disease • PR Newswire (US) • 03/02/2023 12:30:00 PM
- Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension • PR Newswire (US) • 02/28/2023 12:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/15/2023 01:27:30 PM
- Palatin Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 02/15/2023 12:30:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 02/14/2023 09:50:20 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 06:20:30 PM
- Palatin to Report Second Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on February 15, 2023 • PR Newswire (US) • 02/10/2023 12:30:00 PM
- Palatin Initiates Enrollment in the Phase 2 Bremelanotide BREAKOUT Study in Patients with Diabetic Kidney Disease • PR Newswire (US) • 01/19/2023 12:30:00 PM
- Palatin Receives $4.7 Million of Non-Dilutive Funding • PR Newswire (US) • 01/18/2023 12:30:00 PM
- Frontiers in Immunology Publishes Pre-Clinical Study of Palatin's PL8177 Demonstrating Therapeutic Effects in Inflammatory Conditions • PR Newswire (US) • 01/10/2023 12:30:00 PM
- Palatin Announces Preliminary Second Quarter Fiscal 2023 Vyleesi® Product Sales Results • PR Newswire (US) • 01/05/2023 12:30:00 PM
- Amended Statement of Changes in Beneficial Ownership (4/a) • Edgar (US Regulatory) • 12/28/2022 03:30:29 PM
- Amended Statement of Changes in Beneficial Ownership (4/a) • Edgar (US Regulatory) • 12/28/2022 03:30:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/23/2022 10:31:40 PM
- Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Palatin Technologies (PTN) • TipRanks • 11/15/2022 12:05:42 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:51:21 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 01:02:39 PM
- Palatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 11/14/2022 12:30:00 PM
- Palatin to Report First Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on November 14, 2022 • PR Newswire (US) • 11/09/2022 10:16:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/02/2022 09:08:25 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 11/02/2022 02:37:31 PM
- Palatin Announces $10 Million Registered Direct Offering • PR Newswire (US) • 10/31/2022 01:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/25/2022 09:02:40 PM
- Palatin Presents PL8177 Data at American College of Gastroenterology Annual Meeting • PR Newswire (US) • 10/24/2022 09:32:00 PM
- First Patient Enrolled in Palatin's Phase 2 study of PL8177 in Ulcerative Colitis Trial • PR Newswire (US) • 10/20/2022 11:30:00 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM